Cefaxine

Cefaxine may be available in the countries listed below.

Ingredient matches for Cefaxine

Cefalexin

Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Cefaxine in the following countries:

• Bahrain


• Oman

International Drug Name Search

Flukatril

Flukatril may be available in the countries listed below.

Ingredient matches for Flukatril

Fluconazole

Fluconazole is reported as an ingredient of Flukatril in the following countries:

• Greece

International Drug Name Search

Wick Sinex

Wick Sinex may be available in the countries listed below.

Ingredient matches for Wick Sinex

Oxymetazoline

Oxymetazoline hydrochloride (a derivative of Oxymetazoline) is reported as an ingredient of Wick Sinex in the following countries:

• Germany


• Romania

International Drug Name Search

Fanapt

Fanapt is a brand name of iloperidone, approved by the FDA in the following formulation(s):

FANAPT (iloperidone - tablet; oral)

• 
  Manufacturer: NOVARTIS
  
  Approval date: May 6, 2009
  
  Strength(s): 10MG, 12MG, 1MG ^[RLD], 2MG, 4MG, 6MG, 8MG
  

Has a generic version of Fanapt been approved?

No. There is currently no therapeutically equivalent version of Fanapt available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Fanapt. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics
  Patent RE39198
  Issued: July 18, 2006
  Inventor(s): Strupczewski; Joseph T. & Helsley; Grover C. & Chiang; Yulin & Bordeau; Kenneth J. & Glamkowski; Edward J.
  Assignee(s): Aventis Pharmaceuticals Inc.
  Heteroarylpiperidines, pyrrolidines, and piperazines are useful as antipsychotic and analgesic agents. The compounds are especially useful for treating psychoses by administering to a mammal a psychoses-treating effective amounts of one of the compounds. The compounds are also useful as analgesics by administering a pain-relieving effective amount of one of the compounds to a mammal.
  
  Patent expiration dates:
  
  
  • November 15, 2016
    
    ✓ 
    Patent use: INDICATED FOR THE ACUTE TREATMENT OF ADULTS WITH SCHIZOPHRENIA
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • May 6, 2014 - NEW CHEMICAL ENTITY
  
  

See also...

• Fanapt Consumer Information (Drugs.com)
• Fanapt Consumer Information (Wolters Kluwer)
• Fanapt Consumer Information (Cerner Multum)
• Fanapt Advanced Consumer Information (Micromedex)
• Fanapt Titration Pack Advanced Consumer Information (Micromedex)
• Fanapt AHFS DI Monographs (ASHP)
• Iloperidone Consumer Information (Wolters Kluwer)
• Iloperidone Consumer Information (Cerner Multum)
• Iloperidone Advanced Consumer Information (Micromedex)
• Iloperidone AHFS DI Monographs (ASHP)
• Iloperidonesee AHFS DI Monographs (ASHP)

Dicloflame

Dicloflame may be available in the countries listed below.

Ingredient matches for Dicloflame

Diclofenac

Diclofenac is reported as an ingredient of Dicloflame in the following countries:

• Peru

International Drug Name Search

Quinidine Double-Crane Pharm

Quinidine Double-Crane Pharm may be available in the countries listed below.

Ingredient matches for Quinidine Double-Crane Pharm

Quinidine

Quinidine sulfate (a derivative of Quinidine) is reported as an ingredient of Quinidine Double-Crane Pharm in the following countries:

• China

International Drug Name Search

Colace

In the US, Colace (docusate systemic) is a member of the drug class laxatives and is used to treat Constipation.

US matches:

• Colace


• Colace Liquid


• Colace Microenema Enema


• Colace Pediatric Suppositories


• Colace Syrup


• Colace Glycerin Suppositories rectal


• Colace Micro-Enema

Ingredient matches for Colace

Docusate

Docusate Sodium is reported as an ingredient of Colace in the following countries:

• Canada


• United States

Glycerol

Glycerol is reported as an ingredient of Colace in the following countries:

• United States

International Drug Name Search

Monotobrin

Monotobrin may be available in the countries listed below.

Ingredient matches for Monotobrin

Tobramycin

Tobramycin sulfate (a derivative of Tobramycin) is reported as an ingredient of Monotobrin in the following countries:

• Greece

International Drug Name Search

Vistide

Vistide is a brand name of cidofovir, approved by the FDA in the following formulation(s):

VISTIDE (cidofovir - injectable; injection)

• 
  Manufacturer: GILEAD
  
  Approval date: June 26, 1996
  
  Strength(s): EQ 75MG BASE/ML ^[RLD]

Has a generic version of Vistide been approved?

No. There is currently no therapeutically equivalent version of Vistide available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vistide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Vistide.

See also...

• Vistide Consumer Information (Wolters Kluwer)
• Vistide Consumer Information (Cerner Multum)
• Vistide Advanced Consumer Information (Micromedex)
• Vistide AHFS DI Monographs (ASHP)
• Cidofovir Consumer Information (Wolters Kluwer)
• Cidofovir Consumer Information (Cerner Multum)
• Cidofovir Intravenous Advanced Consumer Information (Micromedex)
• Cidofovir AHFS DI Monographs (ASHP)